| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |